Chronic morphine decreases calbindin D(28k) immunoreactivity in a subset of cerebellar Purkinje neurons of rat brain

Brain Research

Volumn 734, Issue 1-2, 1996, Pages 123-134

  Garcia, Meredith M ^a   Gilster, Jason ^a   Harlan, Richard E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dizolcipine; Glutamate; Intracellular calcium; Morphine tolerance; NMDA receptor; Opiate; Opiate tolerance

Indexed keywords

CALBINDIN; DIZOCILPINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CEREBELLUM; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030599195     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00622-1     Document Type: Article

References (77)

1. [1] Adler, E.M., Augustine, G.J., Duffy, S.N. and Charlton, M.P., Alien intracellular calcium chelators attenuate neurotransmitter release at the squid giant synapse, J. Neurosci., 11 (1991) 1496-1507.
2. [2] Alder, R. and Barbas, H., Complementary distribution of the phosphoproteins DARPP-32 and I-1 in the cerebellar system, NeuroReport, 6 (1995) 2368-2372.
3. [3] Baimbridge, K.G. and Miller, J.J., Hippocampal calcium-binding protein during commissural kindling-induced epileptogenesis: progressive decline and effects of anticonvulsants, Brain Res., 324 (1984) 85-90.
4. [4] Baimbridge, K.G., Celio, M.R. and Rogers, J.H., Calcium-binding proteins in the nervous system, Trends Neurosci., 15 (1992) 303-308.
5. [5] Batchelor, A.M. and Garthwaite, J., Novel synaptic potentials in cerebellar Purkinje cells: probable mediation by metabotropic glutamate receptors, Neuropharmacology, 32 (1993) 11-20.
6. [6] Batchelor, A.M., Madge, D.J. and Garthwaite, J., Synaptic activation of metabotropic glutamate receptors in the parallel fibre-Purkinje cell pathway in rat cerebellar slices, Neuroscience, 63 (1994) 911-915.
7. [7] Batini, C., Palestrini, M., Thomasset, M. and Vigot, R., Cytoplasmic calcium buffer, calbindin-D28k, is regulated by excitatory amino acids, NeuroReport, 4 (1993) 927-930.
8. [8] Beitner-Johnson, D. and Nestler, E.J., Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions, J. Neurochem., 57 (1991) 344-347.
9. [9] Bloom, F.E., Hoffer, B.J. and Siggins, G.R., Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. I. Localization of the fibers and their synapses, Brain Res., 25 (1971) 501-521.
10. [10] Bloom, F.E., Hoffer, B.J. and Siggins, G.R., Norepinephrine mediated cerebellar synapses: a model system for neuropsychopharmacology, Biol. Psychiatry, 4 (1972) 157-177.
11. [11] Bongianni, F., Carla, V., Moroni, F. and Pellegrini-Giampietro, D.E., Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats, Br. J. Pharm., 88 (1986) 561-567.
12. [12] Brady, L.S. and Holtzman, S.G., Locomotor activity in morphine-dependent and post-dependent rats, Pharmacol. Biochem. Behav., 14 (1981) 361-370.
13. [13] Cardenas, H.L. and Ross, D.H., Morphine induced calcium depletion in discrete regions of rat brain, J. Neurochem., 24 (1975) 487-493.
14. [14] Celio, M.R., Calbindin D-28k and parvalbumin in the rat nervous system, Neuroscience, 35 (1990) 375-475.
15. [15] Chard, P.S., Bleakman, D., Christakos, S., Fullmer, C.S. and Miller, R.J., Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurons, J. Physiol., 472 (1993) 341-357.
16. [16] Chard, P.S., Jordan, J., Marcuccilli, C.J., Miller, R.J., Leiden, J.M., Roos, R.P. and Ghadge, G.D., Regulation of excitatory transmission at hippocampal synapses by calbindin D28k, Proc. Natl. Acad. Sci. USA, 92 (1995) 5144-5148.
17. [17] Charuchinda, C., Supavali, P., Karobath, M. and Palacios, J.M., Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand, J. Neurosci., 7 (1987) 1352-1360.
18. [18] Choi, D.W., Excitotoxic cell death, J. Neurobiol., 23 (1992) 1261-1276.
19. [19] Diaz, J., Levesque, D., Lammers, C.H., Griffon, N., Martres, M.-P., Schwartz, J.-C. and Sokoloff, P., Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain, Neuroscience, 65 (1995) 731-745.
20. [20] Dzoljic, E.D., Kaplan, C.D. and Dzoljic, M.R., Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats, Arch. Int. Pharmacodyn. Ther., 294 (1988) 64-70.
21. [21] Fabian, I. and Ableitner, A., Brain sites involved in μ-opioid receptor-mediated actions: a 2-deoxyglucose study, Brain Res., 697 (1995) 205-215.
22. 3H]nimodipine receptor binding in rat brain regions, Neurochem. Res., 13 (1988) 1175-1181.
23. [23] Garcia, M.M. and Harlan, R.E., Stimulus-transcription coupling at the mu opiate receptor. In R.P. Hammer (Ed.), The Neurobiology of Opiates, CRC Press, Boca Raton, 1993, pp. 257-299.
24. [24] Garcia, M.M. and Harlan, R.E., Chronic morphine increases calbindin D28k in rat striatum: possible NMDA receptor involvement, NeuroReport, 5 (1993) 65-68.
25. [25] Garthwaite, G., Yamini, B. and Garthwaite, J., Selective loss of Purkinje and granule cell responsiveness to N-methyl-D-aspartate in rat cerebellum during development, Dev. Brain Res., 36 (1987) 288-292.
26. [26] Garthwaite, J. and Beaumont, P.S., Excitatory amino acid receptors in the parallel fiber pathway in rat cerebellar slices, Neurosci. Lett., 107 (1989) 151-156.
27. [27] Garthwaite, J. and Brodbelt, A.R., Synaptic activation of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the mossy fibre pathway in adult and immature rat cerebellar slices, Neuroscience, 29 (1989) 401-412.
28. [28] Glick, S.D., Rossman, K., Steindorf, S., Maisonneuve, I.M. and Carlson, J.N., Effects and aftereffects of ibogaine on morphine self-administration in rats, Eur. J. Pharmacol., 195 (1991) 341-345.
29. [29] Glick, S.D., Rossman, K., Rao, N.C., Maisonneuve, I.M. and Carlson, J.N., Effects of ibogaine on acute signs of morphine withdrawal in rats: independent from tremor, Neuropharmacology, 31 (1992) 497-500.
30. 2+ uptake, J. Pharmacol. Exp. Ther., 209 (1979) 132-136.
31. [31] Guerrero-Munoz, F., De Lourdes Guerrero, M. and Way, E.L., Effect of morphine on calcium uptake by lysed synaptosomes, J. Pharmacol. Exp. Ther., 211 (1979) 370-374.
32. [32] Harlan, R.E., Shivers, B.D., Romano, G.J., Howells, R.D. and Pfaff, D.W., Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization, J. Comp. Neurol., 258 (1987) 159-184.
33. [33] Heizmann, C.W. and Hunziker, W., Intracellular calcium-binding proteins: more sights than insights, Trends Biochem. Sci., 16 (1991) 98-103.
34. [34] Iacopino, A.M. and Christakos, S.J., Corticosterone regulates calbindin-D28k mRNA and protein levels in rat hippocampus, J. Biol. Chem., 265 (1990) 10177-10180.
35. [35] Ikai, Y., Takada, M., Shinonaga, Y. and Mizuno, N., Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei, Neuroscience, 51 (1992) 719-728.
36. [36] Janowsky, A., Neve, K.A., Kinzie, J.M., Taylor, B., de Paulis, T. and Belknap, J.K., Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine, J. Pharmacol. Exp. Ther., 261 (1992) 1282-1290.
37. [37] Jenab, S., Kest, B., Franklin, S.O. and Inturrisi, C.E., Quantitative distribution of the delta opioid receptor mRNA in the mouse and rat CNS, Life Sci., 56 (1995) 2343-2355.
38. [38] Kadowaki, K., McGowan, E., Mock, G., Chandler, S. and Emson, P., Distribution of calcium binding protein mRNA in rat cerebellar cortex, Neurosci. Lett., 153 (1993) 80-84.
39. [39] Kohr, G. and Mody, I., Endogenous intracellular calcium buffering and the activation/inactivation of HVA calcium currents in rat dentate gyrus granule cells, J. Gen. Physiol., 98 (1991) 941-967.
40. [40] Kohr, G., Lambert, C.E. and Mody, I., Calbindin-D28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons, Exp. Brain Res., 85 (1991) 543-551.
41. [41] Llano, I., Marty, A., Armstrong, C.M. and Konnerth, A., Synaptic- and agonist-induced excitatory currents of Purkinje cells in rat cerebellar slices, J. Physiol., 434 (1991) 183-213.
42. 2+ homeostasis, Neuron, 9 (1992) 943-954.
43. [43] Lomri, N., Perret, C., Gouhier, N. and Thomasset, M., Cloning and analysis of calbindin-D28k cDNA and its expression in the central nervous system, Gene, 80 (1989) 87-98.
44. [44] Lowenstein, D.H., Miles, M.F., Hatam, F. and McCabe, T., Up regulation of calbindin-D28k mRNA in the rat hippocampus following focal stimulation of the perforant path, Neuron, 6 (1991) 627-633.
45. [45] Lowenstein, D.H., Gwinn, R.P., Serena Seren, M., Simon, R.P. and McIntosh, T.K., Increased expression of mRNA encoding calbindin-D28k, the glucose-regulated proteins, or the 72 kDa heat-shock protein in three models of CNS injury, Mol. Brain Res., 22 (1994) 299-308.
46. [46] Mansour, A., Meador-Woodruff, J.H., Zhou, Q.-Y., Civelli, O., Akil, H. and Watson, S.J., A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques, Neuroscience, 45 (1991) 359-371.
47. [47] Mansour, A., Thompson, R.C., Akil, H. and Watson, S.J., Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA, J. Chem. Neuroanat., 6 (1993) 351-362.
48. [48] Mansour, A., Fox, C.A., Burke, S., Meng, F., Thompson, R.C, Akil, H. and Watson, S.J., Mu, delta and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study, J. Comp. Neurol., 350 (1994) 412-438.
49. [49] Mansour, A., Fox, C.F., Thompson, R.C., Akil, H. and Watson, S.J., Mu-opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding, Brain Res., 643 (1994) 245-265.
50. [50] Mansour, A., Fox, C.A., Burke, S., Akil, H. and Watson, S.J., Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS, J. Chem. Neuroanat., 8 (1995) 283-305.
51. [51] Mattson, M.P., Rychlik, B., Chu, C. and Christakos, S., Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin D28k in cultured hippocampal neurons, Neuron, 6 (1991) 41-51.
52. [52] Mei, Y.A., Griffon, N., Buquet, C., Martres, M.P., Vaudry, H., Schwartz, J.-C., Sokoloff, P. and Cazin, L., Activation of dopamine D4 receptor inhibits an L-type calcium current in cerebellar granule cells, Neuroscience, 68 (1995) 107-116.
53. [53] Melchiorri, P., Maritati, M., Negri, L. and Erspamer, V., Long-term sensitization to the activation of cerebral delta-opioid receptors by the deltorphin Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 in rats exposed to morphine, Proc. Natl. Acad. Sci. USA, 89 (1992) 3696-3700.
54. [54] Mengod, G., Martinez-Mir, M.I., Vilaro, M.T. and Palacios, J.M., Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry, Proc. Natl. Acad. Sci. USA, 86 (1989) 8560-8564.
55. [55] Miller, J.J. and Baimbridge, K.G., Biochemical and immunohistochemical correlates of kindling-induced epilepsy: role of calcium binding protein, Brain Res., 278 (1983) 322-326.
56. 2+ binding domains, and numerous promoter regulatory elements, Mol. Endocrinol., 2 (1988) 355-367.
57. [57] Nestler, E.J., Molecular mechanisms of drug addiction, J. Neurosci., 12 (1992) 2439-2450.
58. [58] Nicoll, R.A., Siggins, G.R., Ling, N., Bloom, F.E. and Guilleman, R., Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study, Proc. Natl. Acad. Sci. USA, 74 (1977) 2584-2588.
59. [59] O'Hearn, E. and Molliver, M.E., Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline, Neuroscience, 55 (1993) 303-310.
60. [60] Osugi, T., Taniura, H., Ikemoto, M. and Miki, N., Effects of chronic exposure of NG108-15 cells to morphine or ethanol on binding of nuclear factors to cAMP response element, Biochem. Biophys. Res. Commun., 174 (1991) 25-31.
61. [61] Osugi, T., Ikemoto, M., Tanaka, H., Wang, X.-B. and Miki, N., Modulation by chronic morphine administration of single-stranded cAMP response element (ssCRE) binding proteins in the mouse cerebellum, Mol. Brain Res., 21 (1994) 256-262.
62. [62] Palay, S.L. and Chan-Palay, V., Cerebellar Cortex. Cytology and Organization, Springer-Verlag, New York, 1974.
63. [63] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1986.
64. [64] Perkel, D.J., Hestrin, S., Sah, P. and Nicoll, R.A., Excitatory synaptic currents in Purkinje cells, Proc. R. Soc. B Lond., 241 (1990) 116-121.
65. [65] Petralia, R.S., Yokotani, N. and Wenthold, R.J., Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody, J. Neurosci., 114 (1994) 667-696.
66. [66] Popik, P., Layer, R.T., Fossom, L.H., Benveniste, M., Geteeer-Douglas, B., Witkin, J.M. and Skolnick, P., NMDA antagonist properties of the putative antiaddictive drug, ibogaine, J. Pharmacol. Exp. Ther., 275 (1995) 753-760.
67. [67] Ramkumar, V. and El-Fakahany, E.E., Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence, Eur. J. Pharmacol., 146 (1988) 73-83.
68. [68] Ricci, A., Vega, J.A., Loredana Mammola, C. and Amenta, F., Localisation of dopamine D3 receptor in the rat cerebellar cortex: a light microscope autoradiographic study, Neurosci. Lett., 190 (1995) 163-166.
69. [69] Ross, C.A., Bredt, D. and Snyder, S.H., Messenger molecules in the cerebellum, Trends Neurosci., 13 (1990) 216-222.
70. 3H]SCH23390, Brain Res., 375 (1986) 291-301.
71. [71] Scharfman, H.E. and Schwartzkroin, P.A., Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation, Science, 246 (1989) 257-260.
72. [72] Sonnenberg, J.L., Frantz, G.D., Lee, S., Heick, A., Chu, C., Tobin, A.J. and Christakos, S., Calcium binding protein (calbindin-D28k) and glutamate decarboxylase gene expression after kindling induced seizures, Mol. Brain Res., 9 (1991) 179-190.
73. [73] Suzuki, Y. and Taguchi, K., Influence of drugs on evoked potentials in the cat cerebellum. I. Effects of morphine hydrochloride (1), Jpn. J. Pharmacol., 33 (1983) 671-679.
74. [74] Taguchi, K. and Suzuki, Y., Effects of microiontophoretically-applied morphine on the Purkinje cell in the cerebellum of the cat, Neuropharmacology, 28 (1989) 235-242.
75. [75] Tirumalai, P.S. and Howells, R.D., Regulation of calbindin-D28k gene expression in response to acute and chronic morphine administration, Mol. Brain Res., 23 (1994) 144-150.
76. [76] Yamamoto, H., Harris, R.A., Loh, H.H. and Way, E.L., Effects of acute and chronic morphine treatments on calcium localization and binding in brain, J. Pharmacol. Exp. Ther., 205 (1978) 255-264.
77. 3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord, J. Comp. Neurol., 344 (1994) 121-136.